- Home
- IAUX vs ATAI Comparison
IAUX vs ATAI Comparison
Compare IAUX & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$4.17
Company Overview
Basic Information| Metric | IAUX | ATAI |
|---|---|---|
| Founded | 2020 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | IAUX | ATAI |
|---|---|---|
| Price | $1.82 | $4.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 7 |
| Target Price | $1.50 | ★ $13.86 |
| AVG Volume (30 Days) | ★ 6.3M | 4.0M |
| Earning Date | 11-12-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $97,131,000.00 | $3,018,000.00 |
| Revenue This Year | $85.81 | $962.66 |
| Revenue Next Year | $97.70 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 83.46 | ★ 811.78 |
| 52 Week Low | $0.48 | $1.15 |
| 52 Week High | $1.85 | $6.75 |
Technical Indicators
Market Signals| Indicator | IAUX | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 74.64 | 57.09 |
| Support Level | $1.51 | $3.50 |
| Resistance Level | $1.85 | $3.85 |
| Average True Range (ATR) | 0.09 | 0.22 |
| MACD | 0.02 | 0.04 |
| Stochastic Oscillator | 92.50 | 99.34 |
Price Performance
Historical Comparison IAUX
ATAI
About IAUX i-80 Gold Corp.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.